ncRNA name | hsa-miR-210 |
ncRNA Category | miRNA |
Disease name | von Hippel-Lindau disease |
Species | Homo sapiens |
Tissues/Cell_line | blood |
Methods | qRT-PCR |
Expression pattern | associated |
Functional description | Mir210 is a micro-RNA responsive to hypoxia that we have used as a new putative biomarker to follow VHL patient evolution during the clinical trial. |
PubMed ID | 28662711 |
Year | 2017 |
Title | Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease. |
Drug-related ncRNA | NO |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.